SHINE and Primo Biotech Partner to Advance Precision Cancer Care in Asia-Pacific

About SHINE Technologies

Based in Janesville, Wisconsin, SHINE specializes in the production of n.c.a. Lu-177 and other medical isotopes. Through innovative fusion technology, SHINE is advancing cancer treatment and diagnostics while exploring applications in healthcare and sustainable energy. Learn more at www.shinefusion.com.

Media Contact:

shine.fusion@highwirepr.com

About Primo Biotechnology

Primo Biotechnology is a leader in Asia’s nuclear medicine sector, dedicated to developing and delivering high-precision radiopharmaceuticals. Committed to personalized cancer care, Primo’s vision, Future in Precision, drives its mission to improve healthcare outcomes. Visit www.primobt.com for more information.

Media Contact:

Primo Biotechnology Co., Ltd.
Sunny Chen
Marketing Manager
sunny.chen@primobt.com